Anhedonia is a severe condition that describes a nearcomplete absence of enjoyment, motivation, and interest. A core feature of depression, clinical manifestations of anhedonia can include deficits in experiencing pleasure, approach-related motivated behavior, and learning how to match expectations to the environment. To date, the precise neurobiological mechanisms of anhedonia in major depression are still poorly understood. We have previously argued that contradictory findings and the inability to identify specific neurobiological substrates for anhedonic symptoms may result from sample heterogeneity, suboptimal methods of assessment, and the challenge of dissociating between different components of anhedonia. Recently, however, computational advances to the operationalization of psychiatric symptoms have enhanced the ability to evaluate the neurobiology of constituent elements of this symptom domain. In this paper, we review (1) advances in behavioral and computational methods of assessing reward processing and motivation and (2) the development of new selfreport, neurological, and biological methods of subtyping that may be useful in future pursuits to expand our understanding of the neurobiology of anhedonia in depression. Anhedonia, a core feature of depression, is a multi-faceted symptom that includes deficits in the experience of pleasure, reduced approach-related motivated behavior, and/or impaired learning about rewards in the environment (see Box 1) [1]. We have previously argued that the elusiveness of neurobiological substrates for anhedonia in depression results from the use of suboptimal methods of assessment, which fail to dissociate between these different components of anhedonia and result in pathophysiological heterogeneity. Anhedonia in mood disorders has long been hypothesized to be related to a reduction in dopamine (DA) transmission [2][3][4]. While neuroimaging and pharmacological manipulations have provided some support for the hypothesis that DA may be affected in at least some individuals with major depression [5][6][7], findings remain mixed (for a review, see [1]), and more work is needed to understand the neurobiology of anhedonia in depression.
Anhedonia, a core feature of depression, is a multi-faceted symptom that includes deficits in the experience of pleasure, reduced approach-related motivated behavior, and/or impaired learning about rewards in the environment (see Box 1) [1] . We have previously argued that the elusiveness of neurobiological substrates for anhedonia in depression results from the use of suboptimal methods of assessment, which fail to dissociate between these different components of anhedonia and result in pathophysiological heterogeneity. Anhedonia in mood disorders has long been hypothesized to be related to a reduction in dopamine (DA) transmission [2] [3] [4] . While neuroimaging and pharmacological manipulations have provided some support for the hypothesis that DA may be affected in at least some individuals with major depression [5] [6] [7] , findings remain mixed (for a review, see [1] ), and more work is needed to understand the neurobiology of anhedonia in depression.
Within the last five years the field of psychiatry has moved in several new directions that hold promise for improving methods of assessment and increasing our understanding of the underlying neurobiology, including the possible role of DAergic deficits. In this review, we outline two new lines of research. First, the emergence of computational psychiatry [8] has encouraged the application of computational methods to improve our understanding of mental illness, including the use of computational modeling for making inferences regarding the underlying mechanisms that generate observed behavior in psychiatric groups [9, 10] (Figure 1 ). This includes the use of behavioral paradigms and computational models that have been previously linked to DAergic signaling in animal models and human subjects, providing opportunities to evaluate the prevalence of DA-related deficits in patients with depression and anhedonia. Here we focus on advances in the use of reinforcement learning and effort-based choice to evaluate reward processing and motivational deficits.
Second, recent work has also encouraged the identification of subgroups within heterogeneous disorders for which individualized treatments can be developed [9] , and has resulted in increased efforts to identify behaviorally, neurologically, or biologically distinct subgroups within and across diagnostic categories. One candidate sub-group with growing empirical support is the so-called 'inflammatory sub-type' [11 ] , which may be driven by immune-induced alterations in DAergic tone and basal ganglia function. In the sections that follow, we outline recent work in these domains and advocate for further integration of these lines of research to extend our understanding of neurobiological mechanisms associated with anhedonia in depression.
